References
- Aguirre-Ghiso JA. Models, mechanisms and clinical evidence for cancer dormancy. Nat Rev Cancer 2007; 7:834 - 46; http://dx.doi.org/10.1038/nrc2256; PMID: 17957189
- Koebel CM, Vermi W, Swann JB, Zerafa N, Rodig SJ, Old LJ, Smyth MJ, Schreiber RD. Adaptive immunity maintains occult cancer in an equilibrium state. Nature 2007; 450:903 - 7; http://dx.doi.org/10.1038/nature06309; PMID: 18026089
- Romero I, Garrido C, Algarra I, Collado A, Garrido F, Garcia-Lora AM. T lymphocytes restrain spontaneous metastases in permanent dormancy. Cancer Res 2014; 74:1958 - 68; http://dx.doi.org/10.1158/0008-5472.CAN-13-2084; PMID: 24531750
- Garrido A, Pérez M, Delgado C, Garrido ML, Rojano J, Algarra I, Garrido F. Influence of class I H-2 gene expression on local tumor growth. Description of a model obtained from clones derived from a solid BALB/c tumor. Exp Clin Immunogenet 1986; 3:98 - 110; PMID: 3274051
- Garrido C, Romero I, Berruguilla E, Cancela B, Algarra I, Collado A, García-Lora A, Garrido F. Immunotherapy eradicates metastases with reversible defects in MHC class I expression. Cancer Immunol Immunother 2011; 60:1257 - 68; http://dx.doi.org/10.1007/s00262-011-1027-1; PMID: 21553283
- Mocikat R, Braumüller H, Gumy A, Egeter O, Ziegler H, Reusch U, Bubeck A, Louis J, Mailhammer R, Riethmüller G, et al. Natural killer cells activated by MHC class I(low) targets prime dendritic cells to induce protective CD8 T cell responses. Immunity 2003; 19:561 - 9; http://dx.doi.org/10.1016/S1074-7613(03)00264-4; PMID: 14563320
- Domingo-Domenech J, Vidal SJ, Rodriguez-Bravo V, Castillo-Martin M, Quinn SA, Rodriguez-Barrueco R, Bonal DM, Charytonowicz E, Gladoun N, de la Iglesia-Vicente J, et al. Suppression of acquired docetaxel resistance in prostate cancer through depletion of notch- and hedgehog-dependent tumor-initiating cells. Cancer Cell 2012; 22:373 - 88; http://dx.doi.org/10.1016/j.ccr.2012.07.016; PMID: 22975379
- Landsberg J, Kohlmeyer J, Renn M, Bald T, Rogava M, Cron M, Fatho M, Lennerz V, Wölfel T, Hölzel M, et al. Melanomas resist T-cell therapy through inflammation-induced reversible dedifferentiation. Nature 2012; 490:412 - 6; http://dx.doi.org/10.1038/nature11538; PMID: 23051752
- Garrido C, Paco L, Romero I, Berruguilla E, Stefansky J, Collado A, Algarra I, Garrido F, Garcia-Lora AM. MHC class I molecules act as tumor suppressor genes regulating the cell cycle gene expression, invasion and intrinsic tumorigenicity of melanoma cells. Carcinogenesis 2012; 33:687 - 93; http://dx.doi.org/10.1093/carcin/bgr318; PMID: 22219178
- Romero I, Martinez M, Garrido C, Collado A, Algarra I, Garrido F, Garcia-Lora AM. The tumour suppressor Fhit positively regulates MHC class I expression on cancer cells. J Pathol 2012; 227:367 - 79; http://dx.doi.org/10.1002/path.4029; PMID: 22451343